Relay Therapeutics Insider Sold Shares Worth $331,131, According to a Recent SEC Filing
Thomas Catinazzo, Chief Financial Officer, on July 06, 2026, sold 17,717 shares in Relay Therapeutics (RLAY) for $331,131. Following the Form 4 filing with the SEC, Catinazzo has control over a total of 159,744 common shares of the company, with 159,744 shares held directly. SEC Filing:
Story updates
09:13:39 PM UTC
SquawkNews
Relay Therapeutics Insider Sold Shares Worth $943,736, According to a Recent SEC Filing
Sanjiv Patel, Director, President, and CEO, on July 07, 2026, sold 48,199 shares in Relay Therapeutics (RLAY) for $943,736.
Following the Form 4 filing with the SEC, Patel has control over a total of 1,502,801 common shares of the company, with 615,898 shares held directly and 886,903 controlled indirectly.
SEC Filing: